# Chicago Atlantic BDC, Inc.: overview LIEN · Nasdaq · CIK 1843162 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/lien.md) · [Financials](/companies/lien/financials.md) · [Filings](/companies/lien/filings.md) · [Insiders](/companies/lien/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.03)](/filings/0001193125-25-278786.md) | not reported | [0.33](/filings/0001193125-26-222738.md) | [0.38](/filings/0001193125-26-347342.md) | [0.39](/filings/0001193125-25-278786.md) | not reported | [0.37](/filings/0001193125-26-222738.md) | [0.27](/filings/0001193125-26-347342.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2022-03-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [(0.64)](/filings/0001140361-24-015752.md) | [1.18](/filings/0001193125-26-115112.md) | [0.93](/filings/0001193125-26-115112.md) | [1.46](/filings/0001193125-26-115112.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/lien/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [INTREPID CAPITAL MANAGEMENT INC](/funds/1092838.md) | 2026-06-30 | $7.4m | 756,185 | | Unchanged | | [Sowell Financial Services LLC](/funds/1633697.md) | 2026-06-30 | $5.0m | 511,387 | | Added +17,950 | | [MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.](/funds/1705339.md) | 2026-06-30 | $1.9m | 189,596 | | Added +7,466 | | [Corient Private Wealth LP](/funds/1948780.md) | 2026-06-30 | $1.8m | 188,863 | | Reduced −191,885 | | [CDC Financial, Inc.](/funds/2077836.md) | 2026-06-30 | $1.7m | 177,391 | | Added +17,773 | | [CONDOR CAPITAL MANAGEMENT](/funds/1082491.md) | 2026-06-30 | $1.6m | 163,673 | | Added +2,214 | | [HighTower Advisors, LLC](/funds/1462245.md) | 2026-06-30 | $1.5m | 155,924 | | Reduced −17,700 | | [PARTNERS CAPITAL INVESTMENT GROUP, LLP](/funds/1694870.md) | 2026-06-30 | $1.4m | 145,336 | | New +145,336 | | [Black Maple Capital Management LP](/funds/1588959.md) | 2026-06-30 | $1.3m | 130,920 | | Unchanged | | [RAYMOND JAMES FINANCIAL INC](/funds/720005.md) | 2026-06-30 | $939.2k | 96,131 | | New +96,131 | ## Recent filings [All 210 filings](/companies/lien/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-08-13 | 11:02 ET | [8-K](/filings/0001213900-26-088673.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-088673 | | 2026-08-13 | 22:41 ET | [10-Q](/filings/0001193125-26-347342.md) | Quarterly report, period 2026-06-30 | 0001193125-26-347342 | | 2026-06-25 | 20:30 ET | [8-K](/filings/0001213900-26-072075.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-26-072075 | | 2026-06-18 | 11:01 ET | [8-K](/filings/0001213900-26-069853.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-069853 | | 2026-05-14 | 11:05 ET | [8-K](/filings/0001213900-26-056216.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-056216 | | 2026-05-14 | 11:00 ET | [10-Q](/filings/0001193125-26-222738.md) | Quarterly report, period 2026-03-31 | 0001193125-26-222738 | | 2026-04-30 | 22:00 ET | [DEF 14A](/filings/0001193125-26-192503.md) | Proxy statement, period 2026-04-29 | 0001193125-26-192503 | | 2026-04-14 | 00:30 ET | [8-K](/filings/0001213900-26-043147.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-043147 | | 2026-03-19 | 11:05 ET | [8-K](/filings/0001213900-26-031536.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-031536 | | 2026-03-19 | 11:00 ET | [10-K](/filings/0001193125-26-115112.md) | Annual report, period 2025-12-31 | 0001193125-26-115112 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-115112.md), filed Mar 19, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1843162 - Tickers: LIEN - Exchange: Nasdaq - SIC code: not reported - State of incorporation: MD - Filer category:
Emerging growth company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.